SCHEMBL5499082

SCHEMBL5499082

O=S(=O)(Cc1ccccc1)C(F)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 2/20 0.52
PRSS2 P07478 2/20 0.52
PRSS3 P35030 2/20 0.52
FAAH O00519 1/20 0.52
ELANE P08246 1/20 0.52
PRTN3 P24158 1/20 0.52
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA5A P35218 1/20 0.47
CA9 Q16790 1/20 0.47
CYP2C19 P33261 1/20 0.44
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
KMT2A Q03164 2/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 2/20 0.41
CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28657406 0.81 PRSS1 (0.58) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL11574577 0.76 CA1 (0.47) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL4130950 0.73 SRC (0.41) CYP2C19TSHRF2SRCALDH1A1
SCHEMBL30207547 0.73 CA1 (0.44) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL6916245 0.73 CA1 (0.44) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL750558 0.72 CA2 (0.52) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL3252117 0.72 CA1 (0.52) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL3626579 0.72 CA2 (0.52) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL5671478 0.72 PRSS1 (0.52) PRSS1PRSS2PRSS3FAAHELANE
SCHEMBL18189420 0.72 EPHX1 (0.51) PRSS1PRSS2PRSS3FAAHELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166568-B1 Compositions and methods to inhibit formation of the C5b-9 complex of complement OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 2007-01-23 US disclosed
US-20030166565-A1 Compositions and methods to inhibit formation of the C5b-9 complex of complement OKLAHOMA MEDICAL RESEARCH FOUNDATION 2003-09-04 US disclosed
EP-1053254-A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT Oklahoma Medical Research Foundation (US) 2000-11-22 EP disclosed
WO-1999040115-A9 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT OKLAHOMA MED RES FOUND (US) 2000-01-20 WO disclosed
WO-1999040115-A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) 1999-08-12 WO disclosed
US-5859339-A HYBRIDIZED POLYNUCLEOTIDES COMPRISING A PROMOTER SEQUENCE GREATER THAN ABOUT FIFTY NUCLEOTIDES LINKED TO A HETEROLOGOUS POLYNUCLEOTIDE SEQUENCE USED TO PRODUCE TRANSGENIC PLANTS RESISTANT TO THE PATHOGEN. THE REAGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-01-12 US disclosed
EP-0805860-A2 PROCEDURES AND MATERIALS FOR CONFERRING DISEASE RESISTANCE IN PLANTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-11-12 EP disclosed
WO-1996022375-A2 PROCEDURES AND MATERIALS FOR CONFERRING DISEASE RESISTANCE IN PLANTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-07-25 WO disclosed